Theophylline Treatment for Pseudohypoparathyroidism

Clinical trial NCT03029429 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03029429
Sponsor: Vanderbilt University Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pseudohypoparathyroidism Albright Hereditary Osteodystrophy

Start date: 2018-09-01
Primary completion: 2026-12-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.